GenePlanet
European provider of preventive genetic testing products - NIPT, cancer screening and lifestyle genetics tests - built on next-generation sequencing and in-house R&D.
GenePlanet develops healthcare and lifestyle products built on preventive genetic testing. Founded in 2008 and headquartered in Europe, the company works across next-generation sequencing, preventive genomics and personalised medicine, with in-house research and development forming the core of its technical activity. Its stated aim is to make DNA discovery accessible to people worldwide, combining scientific research with software and data infrastructure to translate genetic data into individual health insights.
The product portfolio spans three areas. Non-invasive prenatal testing (NIPT) applies next-generation sequencing to prenatal screening. Cancer screening tests cover what the company describes as among the widest panels of screened conditions. Lifestyle genetics tests provide personalised insights into nutrition, health predispositions, drug response and lifestyle optimisation. Data security is treated as a distinct engineering concern: the company holds ISO 27001 certification.
GenePlanet operates in more than 50 countries and has served over 300,000 customers globally, drawing on more than 15 years of experience in the field. Its work sits at the intersection of healthcare, diagnostics, genetic testing, preventive medicine and lifestyle and wellness.